The Pediatric Oncology Center of Jingdu Children's Hospital is one of the key characteristic specialties built by the hospital. Integrating medical treatment, teaching, and scientific research, it is committed to providing comprehensive, precise, and personalized diagnosis and treatment services for children with tumors. Relying on the hospital's strong comprehensive strength, the center integrates advantageous resources from multiple disciplines such as hematology and oncology, and tumor surgery, forming an integrated diagnosis and treatment model to provide full-cycle management for children from diagnosis, treatment to rehabilitation.
The department is composed of an expert team led by Professor Wu Minyuan, an expert with outstanding contributions from the State Council, and Professor Sun Yuan, the president. It has rich clinical experience and advanced diagnosis and treatment technologies. The department has multiple wards and transplant wards, and is equipped with an advanced central laboratory, capable of carrying out various advanced treatment methods such as targeted therapy, CAR-T cell therapy, CIK cell therapy, and NK cell therapy. It has significant advantages in various types of leukemia, hemophagocytic syndrome, chronic active EBV infection, bone marrow failure diseases, primary immunodeficiency diseases, genetic metabolic diseases, solid tumors, various types of anemia, hemorrhagic diseases, etc.
In terms of pediatric tumor surgical treatment, it has gathered a group of experts with profound attainments in the field of pediatric tumor surgery, such as Professor Duan Weihong, Professor Huang Liuming, Professor Li Long, and Director Chou Xiaobing. They focus on the surgical treatment of abdominal solid tumors in children, such as hepatoblastoma, pancreatoblastoma, nephroblastoma, and neuroblastoma, and are especially good at the practice and exploration of difficult and high-risk surgeries. The characteristic diagnosis and treatment projects of the department include interventional embolization and radical surgical resection of hepatoblastoma, comprehensive treatment of recurrent and refractory liver tumors, radical surgical resection of nephroblastoma and neuroblastoma, etc.